| Dr Jeffrey Lynn Miller, MD | |
|
2650 Executive Park Nw, Suite 5, Cleveland, TN 37312-2746 | |
| (423) 479-9679 | |
| (423) 559-9046 |
| Full Name | Dr Jeffrey Lynn Miller |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 2650 Executive Park Nw, Cleveland, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972547420 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 36787 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey Lynn Miller, MD 2650 Executive Park Nw, Suite 5, Cleveland, TN 37312-2746 Ph: () - | Dr Jeffrey Lynn Miller, MD 2650 Executive Park Nw, Suite 5, Cleveland, TN 37312-2746 Ph: (423) 479-9679 |
News Archive
Three papers published this month in the open access general medical journal PLoS Medicine investigate how tumors respond to a an important class of drugs used in cancer chemotherapy, known as epidermal growth factor receptor (EGFR) inhibitors.
Merge Healthcare Incorporated today announced its pending $6.05 cash per share offer for AMICAS, Inc.. Merge's proposal, for an aggregate of $248 million, represents a 13% premium to the previously-announced offer for AMICAS from a newly-formed affiliate of Thoma Bravo, LLC for $5.35 cash per share. Merge's current offer follows its offer of $6.00 cash per share that was made during the "go-shop" period contemplated by AMICAS' merger agreement with Thoma Bravo.
Tris Pharma, a specialty pharmaceutical company that develops innovative drug delivery technologies, announced today that the US Food and Drug Administration (FDA) has accepted its Extended Release Carbinoxamine Oral Suspension NDA for the treatment of allergies in kids two years and older. If approved, Tris Pharma's Extended Release Suspension will provide an alternative to the currently available immediate release formulations.
NPR's health blog "Shots" previews an upcoming WHO-convened meeting to discuss the recent news that two research teams have created H5N1 bird flu strains that are easily transmissible among ferrets, which are used as lab models for humans.
BioClinica, Inc., a global provider of clinical trial services, today announced that it has acquired privately-held Tourtellotte Solutions, Inc. (Tourtellotte), a leader in software and services for the bio-pharmaceutical industry.
› Verified 8 days ago
Calvin Richard Kurz, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2305 Chambliss Ave Nw, Cleveland, TN 37311 Phone: 423-559-6000 | |
Dr. Kellie Ann Taylor, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2305 Chambliss Ave Nw, Cleveland, TN 37311 Phone: 423-559-6000 | |
Matthew Plott, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2305 Chambliss Ave Nw, Cleveland, TN 37311 Phone: 706-264-4603 | |
Dr. Sharon Gail Huggins-felix, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2650 Executive Park Nw, Suite 5, Cleveland, TN 37312 Phone: 423-479-9679 Fax: 423-559-9046 | |
Dr. Timothy Keith Crumpler, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2650 Executive Park Nw, Suite 5, Cleveland, TN 37312 Phone: 423-479-9679 Fax: 423-559-9046 | |
Dr. Beth Ann Schnars, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2650 Executive Park Nw, Suite 5, Cleveland, TN 37312 Phone: 423-479-9679 Fax: 423-559-9046 | |
Dr. Marlene A. Catanese, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1420 Fritz Street, Cleveland, TN 37323 Phone: 423-338-8995 Fax: 423-338-8996 |